MicroRNAs (miRNAs) are emerging as biomarkers for the detection and prognosis of
cancers due to their inherent stability and resilience. To summarize the evidence regarding …

Exosomal miRNAs have attracted much attention due to their critical role in regulating genes
and the altered expression of miRNAs in virtually all cancers affecting humans (Sun et al. in …

Renal cell carcinoma (RCC) is a major pathological type of kidney cancer and is one of the
most common malignancies worldwide. The unremarkable symptoms of early stages …

Simple Summary The incidence of renal cell carcinoma (RCC) rises globally with the highest
rates in developed countries. This indicates not only the impact of advanced imaging, but …

Simple Summary The survival of patients with the most common type of kidney cancer
(called Clear cell renal cell carcinoma—ccRCC) would dramatically improve if it was …

The incidence of small renal masses (SRM) is increasing around the world largely due to the
increasing use of abdominal imaging. 1, 2 Although 10–30% of these SRM are benign, the …

The lack of symptoms at the early stages of clear cell renal cell carcinoma (ccRCC) allows
the tumour to metastasize, leading to a dramatic reduction in patient survival. Therefore, we …

Renal cell carcinoma (RCC) is the second lethal urogenital malignancy with the increasing
incidence and mortality in the world. Clear cell renal cell carcinoma (ccRCC) is one major …

Renal cell carcinomas (RCC) account for 2–3% of the global cancer burden and are
characterized by the highest mortality rate among all genitourinary cancers. However …

Context The epidemiological signature of renal cell carcinoma (RCC) during the past
decades is explained by overdetection and overtreatment of indolent cancers; furthermore, a …